Understanding Fish Consumption Habits During Pregnancy
A Qualitative Study of Fish Consumption During Pregnancy
2 other identifiers
observational
22
1 country
1
Brief Summary
Many pregnant women in the US do not consume enough docosahexaenoic acid (DHA), an essential nutrient found in fish. Apparently conflicting findings that fish consumption is beneficial for the developing fetus, yet potentially toxic because of mercury contamination, have created uncertainty about the appropriate fish consumption advice to provide pregnant women. The investigators objective was to determine knowledge, behaviors, and received advice regarding fish consumption among pregnant women who are infrequent consumers of fish.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2009
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 3, 2010
CompletedFirst Posted
Study publicly available on registry
August 10, 2010
CompletedSeptember 15, 2025
August 1, 2010
5 months
August 3, 2010
September 8, 2025
Conditions
Keywords
Eligibility Criteria
Women aged 18+ who are currently pregnant and who consume \<2 weekly fish servings
You may qualify if:
- currently pregnant
- age at least 18 years
You may not qualify if:
- unable to speak or understand English
- consuming 2 or more weekly fish servings
- unable to eat fish (e.g. allergy, dietary restriction)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Harvard Pilgrim Health Care Institute
Boston, Massachusetts, 02215, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Emily Oken, MD, MPH
Harvard Pilgrim Health Care Institute
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 3, 2010
First Posted
August 10, 2010
Study Start
October 1, 2009
Primary Completion
March 1, 2010
Study Completion
March 1, 2010
Last Updated
September 15, 2025
Record last verified: 2010-08